Skip to content
← Full study record

NCT02283658 · MORE INFO

Limitations, agreements, and source contact

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · Source last updated 2020-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
gcolonotero@mayo.edu
organization
Mayo Clinic
phone
(904) 953-2000
title
Gerardo Colon-Otero, M.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
gcolonotero@mayo.edu
organization
Mayo Clinic
phone
(904) 953-2000
title
Gerardo Colon-Otero, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice